• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Regulation of vitamin K-dependent protein S. Inactivation by thrombin.

作者信息

Walker F J

出版信息

J Biol Chem. 1984 Aug 25;259(16):10335-9.

PMID:6236214
Abstract

Thrombin treatment of the vitamin K-dependent protein S resulted in the loss of the activated protein C cofactor activity associated with protein S. The addition of phospholipid vesicles inhibited the inactivation. Thrombin treatment did not alter the molecular weight of the native protein. However, upon reduction, a peptide of approximately 3000 daltons was released from the treated protein. The interaction between calcium and protein S was reduced by thrombin treatment. When the calcium interaction was determined by the quenching of the intrinsic fluorescence of protein S, thrombin treatment appeared to inhibit the interaction between calcium and the protein. When the calcium interaction was observed by measuring the effect on the electrophoretic mobility of the protein, thrombin treatment reduced the interaction between calcium and protein S. However, the effect of thrombin treatment on the interaction between calcium and protein S was less than observed by the fluorescent method. This observation suggests that fluorescence quenching may be a result of a structural change induced by calcium binding. Thrombin treatment of protein S appears to uncouple the calcium binding from the structural change. In addition, the interaction between protein S and phospholipid vesicles was reduced by thrombin treatment. These results suggest that the thrombin conversion of protein S into a two-chain protein causes the loss of a calcium-induced change in protein structure, loss of the lipid-binding properties, and the loss of cofactor activity.

摘要

相似文献

1
Regulation of vitamin K-dependent protein S. Inactivation by thrombin.
J Biol Chem. 1984 Aug 25;259(16):10335-9.
2
Regulation of activated protein C by thrombin-modified protein S.
J Biochem. 1983 Sep;94(3):699-705. doi: 10.1093/oxfordjournals.jbchem.a134409.
3
Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.由中亚眼镜蛇毒液中纯化的激活剂对牛凝血因子V的激活作用。
Toxicon. 1992 Sep;30(9):1065-79. doi: 10.1016/0041-0101(92)90052-7.
4
Inhibition of human vitamin-K-dependent protein-S-cofactor activity by a monoclonal antibody specific for a Ca2+-dependent epitope.一种针对钙离子依赖性表位的单克隆抗体对人维生素K依赖性蛋白S辅因子活性的抑制作用。
Eur J Biochem. 1987 May 15;165(1):39-45. doi: 10.1111/j.1432-1033.1987.tb11191.x.
5
The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
Eur J Biochem. 1992 Aug 15;208(1):171-8. doi: 10.1111/j.1432-1033.1992.tb17171.x.
6
Properties of chemically modified protein S: effect of the conversion of gamma-carboxyglutamic acid to gamma-methyleneglutamic acid on functional properties.化学修饰蛋白S的特性:γ-羧基谷氨酸转化为γ-亚甲基谷氨酸对功能特性的影响。
Biochemistry. 1986 Oct 7;25(20):6305-11. doi: 10.1021/bi00368a071.
7
The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin.因子Va的轻链含有因子Va的活性,该活性可加速凝血酶对蛋白C的激活。
J Biol Chem. 1983 Jul 25;258(14):8531-4.
8
Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation.蛋白S对活化蛋白C的调节。磷脂在因子Va失活中的作用。
J Biol Chem. 1981 Nov 10;256(21):11128-31.
9
Proteolytic cleavage of vitamin K-dependent bovine plasma protein S by alpha-thrombin and plasma serine protease.α-凝血酶和血浆丝氨酸蛋白酶对维生素K依赖性牛血浆蛋白S的蛋白水解切割。
J Biochem. 1986 Feb;99(2):561-8. doi: 10.1093/oxfordjournals.jbchem.a135512.
10
Protein S and the regulation of activated protein C.蛋白S与活化蛋白C的调节
Semin Thromb Hemost. 1984 Apr;10(2):131-8. doi: 10.1055/s-2007-1004415.

引用本文的文献

1
TAM receptor signaling and autoimmune disease.TAM 受体信号与自身免疫性疾病。
Curr Opin Immunol. 2010 Dec;22(6):740-6. doi: 10.1016/j.coi.2010.10.001. Epub 2010 Oct 26.
2
Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.通过富含γ-羧基谷氨酸结构域的构象变化,蛋白S凝血酶敏感区与膜结合的意义。
Biochem J. 2001 Dec 1;360(Pt 2):499-506. doi: 10.1042/0264-6021:3600499.
3
Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S.
多结构域蛋白抗凝血微蛋白S的化学合成与自发折叠
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14074-8. doi: 10.1073/pnas.260239797.
4
Prediction of solution structures of the Ca2+-bound gamma-carboxyglutamic acid domains of protein S and homolog growth arrest specific protein 6: use of the particle mesh Ewald method.蛋白质S和同源物生长停滞特异性蛋白6的钙离子结合γ-羧基谷氨酸结构域溶液结构的预测:粒子网格埃瓦尔德方法的应用
Biophys J. 1997 Oct;73(4):1847-56. doi: 10.1016/S0006-3495(97)78215-8.
5
[Significance of the endothelium of the vascular wall for maintaining hemostasis].[血管壁内皮对维持止血的意义]
Klin Wochenschr. 1985 Dec 16;63(24):1237-46. doi: 10.1007/BF01738448.
6
Inhibition of the anticoagulant activity of protein S by prothrombin.凝血酶原对蛋白S抗凝活性的抑制作用。
J Clin Invest. 1988 Dec;82(6):2142-7. doi: 10.1172/JCI113836.
7
Cleavage of protein S by a platelet membrane protease.血小板膜蛋白酶对蛋白S的裂解作用。
J Clin Invest. 1987 Feb;79(2):374-9. doi: 10.1172/JCI112822.
8
Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation.人凝血调节蛋白S的cDNA的分离与测序
Proc Natl Acad Sci U S A. 1986 Sep;83(18):6716-20. doi: 10.1073/pnas.83.18.6716.
9
Primary structure of bovine vitamin K-dependent protein S.牛维生素K依赖蛋白S的一级结构
Proc Natl Acad Sci U S A. 1986 Jun;83(12):4199-203. doi: 10.1073/pnas.83.12.4199.
10
The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.补体成分C4b结合蛋白与维生素K依赖蛋白S之间的相互作用在血液凝固和补体系统之间形成了一种联系。
Biochem J. 1991 Aug 1;277 ( Pt 3)(Pt 3):581-92. doi: 10.1042/bj2770581.